Chemoinformaics analysis of eremophila-1(10),7(11)-dien-2-alpha-ol
| Molecular Weight | 220.356 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 13 |
| Exact Molecular Weight | 220.183 | nRing | 2 |
| Solubility: LogS | -4.088 | nHRing | 0 |
| Solubility: LogP | 3.397 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.615 |
| Synth | 4.394 |
| Natural Product Likeliness | 2.797 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.117 |
| Pgp-sub | 0.003 |
| HIA | 0.005 |
| CACO-2 | -4.619 |
| MDCK | 0.0000161 |
| BBB | 0.896 |
| PPB | 0.867554 |
| VDSS | 1.749 |
| FU | 0.0685219 |
| CYP1A2-inh | 0.113 |
| CYP1A2-sub | 0.685 |
| CYP2c19-inh | 0.074 |
| CYP2c19-sub | 0.859 |
| CYP2c9-inh | 0.114 |
| CYP2c9-sub | 0.733 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.593 |
| CYP3a4-inh | 0.04 |
| CYP3a4-sub | 0.303 |
| CL | 12.015 |
| T12 | 0.083 |
| hERG | 0.013 |
| Ames | 0.012 |
| ROA | 0.034 |
| SkinSen | 0.079 |
| Carcinogencity | 0.367 |
| EI | 0.154 |
| Respiratory | 0.127 |
| NR-Aromatase | 0.027 |
| Antiviral | Yes |
| Prediction | 0.909931 |